We believe that: Fasting insulin should be standard, not optional Normal lab ranges are often insufficient for optimization Nutrition, inflammation, and hormonal context must be considered alongside pharmacology This is why we emphasize pre-treatment metabolic mappingnot just for safety, but for precision
Supported by advances in biomanufacturing, evolving regulatory frameworks for biosimilar approval, and strong investment interest, GLP-1 biosimilars are poised to expand patient access to these transformative therapies while promoting cost-effective and sustainable healthcare solutions worldwide
Older age, ongoing vomiting or diarrhea, and chronic conditions like kidney or heart disease all slow the process down
There is currently no established clinical link between Ozempic (semaglutide) and nose bleeds (epistaxis) as a recognised side effect
The Danger: If you lose 20 lbs, and 8 lbs of that is muscle, you have actually slowed down your metabolism